The Whens and Whys of Top Biotech M&A Deals, page-57

NEU is not a pharmaceutical company. It is a successful research and development bio company to bring new therapies to the market.

Taking a Phase II to a Phase III is costly and a minefield. The most obvious hurdle is that Neu is NOT an American company.
This in itself is important. If anyone thinks a newby non American company can waltz in and take over market share from big pharma is delusional.

(Ihave gone on MSB journey for a decade so have the grey hairs to show because of it)

People forget the FDA are not about saving lives, it is about controlling and monitoring the dollars within the drug industry. FDA are paid by big pharma. Huge business.

To go it alone NEU will probably eventually get there but the hurdles will be set high, if they don’t play the game.

To get NEU products ‘on the shelf’ fast, to help families such as Mellan, it is best to not to get too greedy and play the big pharma game, to smell the roses, as I hope Jon will.

Otherwise, sit back and put shares in bottom drawer for it will be a whole lot longer than most on here realise.